Akshay S. Desai

6 ta ish

Brigham and Women's Hospital

1. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

   John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi +35

   Maqola20196 iqtibos

   ABIABI:AkademIndex/2026.other.282514

2. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

   John J.V. McMurray, Milton Packer, Akshay S. Desai +8

   Maqola20146 iqtibos

   ABIABI:AkademIndex/2026.other.295755

3. Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy

   Akshay S. Desai, James C. Fang, William H. Maisel +1

   Sharh maqola20042 iqtibos

   ABIABI:AkademIndex/2026.other.295699

4. Spironolactone for Heart Failure with Preserved Ejection Fraction

   Bertram Pitt, Marc A. Pfeffer, Susan F. Assmann +20

   Maqola20142 iqtibos

   ABIABI:AkademIndex/2026.other.295781

5. Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

   Scott D. Solomon, John J.V. McMurray, Inder S. Anand +31

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.295865

6. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

   Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett +22

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.295867